As more services move online, digital exclusion becomes a sharper divide. Closing libraries removes one of the last ...
The perils of eyeballing BP logs, personalized overnight fasting gains, debating the term “provider,” and more.
For many people, grit – the perseverance and passion for long-term goals – is a virtue. It is also a key ingredient in overcoming challenges, achieving success and maintaining resilience. Studies have ...
Scottish Conservative leader Russell Findlay raises the case of former SNP candidate Sally Donald who is being investigated by Social Security Scotland over benefit fraud claims.
BACKGROUND: Forecasts for the future prevalence of cardiovascular disease and stroke are crucial to guide efforts to improve health outcomes across the life course for women. METHODS: Using historical ...
Ryerson Holding Corporation (NYSE: RYI), a leading value-added processor and distributor of industrial metals, and Olympic Steel, Inc. (formerly NASDAQ: ZEUS), a leading U.S. metals service center, ...
Enbumyst™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to ...
Esperion and Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient therapies for the treatment of edema associated with ...
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital ...
Gong launches Mission Andromeda, adding Gong Enable AI coaching, a sales-focused assistant, unified account management, and Model Context Protocol (MCP) interoperability to connect revenue AI ...
Using longitudinal data on more than 370 000 older Japanese adults, we found that living in constituencies represented by pro-tobacco legislators was associated with higher smoking prevalence. The ...
Adjusted EBITDA(1) increased 8.2% to $594 million, compared to 2024, or 7.8% on a constant currency basis2025 Adjusted EPS(1) of $0.86, an increase of $0.16 per diluted share, compared to ...